Financial News
Pfizer Group B strep vaccine for infants returns encouraging mid-stage trial results
July 19, 2023 at 17:00 PM EDT
Pfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which kills thousands of infants each year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
